These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8243793)

  • 1. Comparative efficacy of salbutamol and salmeterol in exercise-induced asthma.
    Sichletidis L; Daskalopoulou E; Kyriazis G; Kosmidou I; Koupidou S; Pechlivanidis T; Chloros D
    J Int Med Res; 1993; 21(2):81-8. PubMed ID: 8243793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmeterol in exercise-induced bronchoconstriction in asthmatic children: comparison of two doses.
    de Benedictis FM; Tuteri G; Pazzelli P; Niccoli A; Mezzetti D; Vaccaro R
    Eur Respir J; 1996 Oct; 9(10):2099-103. PubMed ID: 8902473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol.
    Revill SM; Morgan MD
    Respir Med; 1998 Aug; 92(8):1053-8. PubMed ID: 9893775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
    Derom EY; Pauwels RA; Van der Straeten ME
    J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma.
    Newnham DM; Ingram CG; Earnshaw J; Palmer JB; Dhillon DP
    Respir Med; 1993 Aug; 87(6):439-44. PubMed ID: 8105520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.
    Castle W; Fuller R; Hall J; Palmer J
    BMJ; 1993 Apr; 306(6884):1034-7. PubMed ID: 8098238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first 20 minutes after a single dose of inhaled salmeterol in asthmatic children.
    Barbato A; Cracco A; Tormena F; Novello A
    Allergy; 1995 Jun; 50(6):506-10. PubMed ID: 7573844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of exercise induced asthma by inhaled salmeterol xinafoate.
    Green CP; Price JF
    Arch Dis Child; 1992 Aug; 67(8):1014-7. PubMed ID: 1355645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol.
    Ramage L; Lipworth BJ; Ingram CG; Cree IA; Dhillon DP
    Respir Med; 1994 May; 88(5):363-8. PubMed ID: 7913549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of protection by inhaled salmeterol in exercise-induced asthma.
    Anderson SD; Rodwell LT; Du Toit J; Young IH
    Chest; 1991 Nov; 100(5):1254-60. PubMed ID: 1682113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours.
    Nowak D; Jörres R; Rabe KF; Lüthke M; Wiessmann J; Magnussen H
    Eur J Clin Pharmacol; 1992; 43(6):591-5. PubMed ID: 1493839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG; Earnshaw JS; Palmer JB
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm.
    Kemp JP; Dockhorn RJ; Busse WW; Bleecker ER; Van As A
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1612-5. PubMed ID: 7952623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol: a novel, long-acting beta 2-agonist.
    Meyer JM; Wenzel CL; Kradjan WA
    Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
    Weiler JM; Nathan RA; Rupp NT; Kalberg CJ; Emmett A; Dorinsky PM
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of and tolerance to salmeterol compared to salbutamol in patients with bronchial asthma].
    De Oliveira MA; Jardim JR; Faresin SM; Lucas SR; Nery LE
    Rev Assoc Med Bras (1992); 1998; 44(3):169-75. PubMed ID: 9755543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction.
    Schaanning J; Vilsvik J; Henriksen AH; Bratten G
    Ann Allergy Asthma Immunol; 1996 Jan; 76(1):57-60. PubMed ID: 8564629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.
    Solèr M; Joos L; Bolliger CT; Elsasser S; Perruchoud AP
    Eur Respir J; 1994 Nov; 7(11):1973-7. PubMed ID: 7875267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.